A Study Of Cardiac Rehabilitation And Atrial Fibrillation
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 25-007422
About this study
The purpose of this study is to survey patients with atrial fibrillation and ascertain their estimated likelihood of participating in a clinical trial of cardiac rehabilitation (CR) versus usual care.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Atrial Fibrillation – including paroxysmal, persistent, permanent.
At least 1 risk factor for atrial fibrillation: Age ≥ 65 years, BMI >25, Hypertension, Diabetes, Coronary heart disease, Heart failure, Stroke/TIA, Sleep apnea, Tobacco use, Alcohol use.
Exclusion Criteria:
Currently eligible for Cardiac Rehabilitation by current Medicare Coverage Decisions (Recent MI, PCI, CABG, Valve Replacement, Heart Transplant, Chronic Stable Angina, HF with EF £ 35%)
Previously attended CR in the past 3 years.
Prognosis anticipated to be < 1 year.
Planned hospitalization, PCI, or other cardiac procedure in the next 3 months.
Unable to complete a baseline exercise test on treadmill.
High risk ischemic results from baseline exercise test or known high risk coronary anatomy.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 7/31/2025. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Randal Thomas, M.D. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available